Vycor Medical FCF per Share
Free Cash Flow per Share of Vycor Medical (VYCO) as of Nov 3, 2026.
Get this data via API
Financial Data API
FCF per Share
-0.00USD
YoY
-134.15%
Last updated:
Free Cash Flow per Share of Vycor Medical is 2025 -0.00 USD. Free Cash Flow per Share of Vycor Medical was 2024 0.00 USD. It decreases by -134.15% lower compared to the previous year.
The Vycor Medical FCF per Share history
3 Years
10 Years
25 Years
Max
FCF per Share
Date
FCF per Share
Jan 1, 2018
-0.01 USD
Jan 1, 2019
-0.00 USD
Jan 1, 2020
-0.01 USD
Jan 1, 2021
-0.00 USD
Jan 1, 2022
-0.01 USD
Jan 1, 2023
0.00 USD
Jan 1, 2024
0.00 USD
Jan 1, 2025
-0.00 USD
| YEAR | FCF per Share | YoY |
|---|---|---|
| -0.00USD | -134.15% | |
| 0.00USD | +167.03% | |
| 0.00USD | -109.09% | |
| -0.01USD | +1,124.56% | |
| -0.00USD | -95.13% | |
| -0.01USD | +386.32% | |
| -0.00USD | -83.35% | |
| -0.01USD | -60.97% | |
| -0.04USD | -66.37% | |
| -0.11USD | -59.76% | |
| -0.26USD | -51.35% | |
| -0.54USD | — |
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Vycor Medical Stock analysis
What does Vycor Medical do? Vycor Medical Inc. is a US-based company specializing in the development and marketing of specialized medical devices and solutions. It was founded in 1989 in Boca Raton, Florida and is now headquartered in Westford, Massachusetts.
The company offers a range of products in various medical fields, including instruments for neurosurgical procedures, devices for brain tumor removal, and treatment of chronic pain. Vycor Medical Inc. focuses on achieving a higher standard in medicine through innovative technologies, aiming to provide better patient care.
One of their key products is the modular SDV™ system, designed to support neurosurgeons in brain surgeries. This transparent device and instrument system enhances visibility in the operating theater, enabling more accurate procedures. The system helps surgeons identify the target tissue and operate with greater precision, reducing complications during and after surgery.
Another important product offered by Vycor Medical Inc. is the ViewSite™ Brain Access System, which is a carrier system for minimally invasive neurosurgical procedures. It ensures visibility during surgery and reduces the risk of complications. The system is designed to improve patient safety and enhance surgical outcomes.
In 2016, Vycor Medical Inc. acquired NovaVision, a company specialized in rehabilitative therapy and visual rehabilitation. This acquisition allows Vycor to expand into the field of vision-related developmental disorders, aiming to provide innovative technologies for better treatment and improved quality of life for patients.
The VBAS® Tissue Harvesting System is another product offered by the company, used for removing damaged skin tissue in various wounds. The VBAS® system improves visibility in the operating theater and helps reduce complications and pain for the patient.
In addition to building a strong portfolio of medical instruments and solutions, Vycor Medical Inc. is actively involved in developing technologies for future medical applications. An example is the Gen3 Glass technology, which enhances contrast perception and reduces glare from operating room lights. The company also offers products such as protective eyewear for physicians.
Overall, Vycor Medical Inc. has a successful history in developing and marketing specialized medical devices and solutions. They have set industry standards with innovative products like the SDV™ system and the ViewSite™ Brain Access System. Collaboration with healthcare professionals and experts is crucial for continuous product development and market growth. Vycor Medical is one of the most popular companies on Eulerpool.
Frequently Asked Questions about Vycor Medical stock
On Eulerpool you can find the complete historical development of Free Cash Flow per Share Vycor Medical since 2006 – with annual values, charts, and detailed analysis.
FCF per share measures the free cash flow allocated to each outstanding share. It is a key metric for assessing shareholder value creation.
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Cash Flow — Vycor Medical
Operating Cash FlowCapital ExpendituresFree Cash FlowFCF per ShareDividends PaidShare BuybacksInvesting Cash FlowFinancing Cash FlowCapEx / RevenueCash Flow per ShareStock-Based CompensationChange in Working CapitalAcquisitions (Net)Net Change in CashCapEx/OCFFCF/Net IncomeFCF ConversionCash ConversionTotal Shareholder PayoutCapEx/D&A
All Key Metrics — Vycor Medical
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth